Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): A protocol for establishing a core outcome set for children with chronic kidney disease

Trials

Volumn 17, Issue 1, 2016, Pages

  Tong, Allison ^a,b   Samuel, Susan ^c   Zappitelli, Michael ^d   Dart, Allison ^e   Furth, Susan ^f   Eddy, Allison ^g   Groothoff, Jaap ^h   Webb, Nicholas J A ⁱ   Yap, Hui Kim ^j   Bockenhauer, Detlef ^k   Sinha, Aditi ^l   Alexander, Stephen I ^b   Goldstein, Stuart L ^m   Gipson, Debbie S ⁿ   Hanson, Camilla S ^a,b   Evangelidis, Nicole ^a,b   Crowe, Sally ^o   Harris, Tess ^p   Hemmelgarn, Brenda R ^q   Manns, Braden ^q   Gill, John ^g   Tugwell, Peter ^r   Van Biesen, Wim ^s   Wheeler, David C ^t   Winkelmayer, Wolfgang C ^u   Craig, Jonathan C ^a,b   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^l ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^m CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^o Crowe Associates Ltd   (United Kingdom)

^p PKD Charity   (United Kingdom)

^q UNIVERSITY OF CALGARY   (Canada)

^r UNIVERSITY OF OTTAWA   (Canada)

^s GHENT UNIVERSITY HOSPITAL   (Belgium)

^t UNIVERSITY COLLEGE LONDON   (United Kingdom)

^u BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Chronic kidney disease; Clinical trials; Core outcome set; Dialysis; Haemodialysis; Outcomes research; Paediatrics; Patient centred outcomes

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; DELPHI STUDY; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW; SYSTEMATIC REVIEW; AGE; BIOASSAY; CHRONIC KIDNEY FAILURE; CONSENSUS; CONSENSUS DEVELOPMENT; COOPERATION; FEMALE; HEALTH STATUS; INFORMATION PROCESSING; INTERDISCIPLINARY COMMUNICATION; INTERVIEW; MALE; METHODOLOGY; MORTALITY; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; STAKEHOLDER ENGAGEMENT; STANDARDS; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; CHILD; CONSENSUS; COOPERATIVE BEHAVIOR; DELPHI TECHNIQUE; ENDPOINT DETERMINATION; FEMALE; FOCUS GROUPS; HEALTH STATUS; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERVIEWS AS TOPIC; KIDNEY TRANSPLANTATION; MALE; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; RISK FACTORS; STAKEHOLDER PARTICIPATION; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84988354962     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1528-5     Document Type: Article

References (61)

1. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Eng J Med. 2004;350(26):2654-62.
2. Moreira JM, Bouissou Morais Soares CM, Teixeira AL, Simões E Silva AC, Kummer AM. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease. Pediatr Nephrol. 2015;30(12):2153-62.
3. Lopes M, Ferraro A, Koch VH. Health-related quality of life of children and adolescents with CKD stages 4-5 and their caregivers. Pediatr Nephrol. 2014;29(7):1239-47.
4. Tong A, Wong G, McTaggart S, Henning P, Mackie F, Carroll RP, Howard K, Craig JC. Quality of life of young adults and adolescents with chronic kidney disease. J Pediatr. 2013;163(4):1179-85.
5. Tong A, Lowe A, Sainsbury P, Craig JC. Experiences of parents who have children with chronic kidney disease: a systematic review of qualitative studies. Pediatr. 2008;121(2):349-60.
6. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, et al. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatr. 2010;125(2):e349-357.
7. Tong A, Tjaden L, Howard K, Wong G, Morton R, Craig JC. Quality of life of adolescent kidney transplant recipients. J Pediatr. 2011;159(4):670-5.
8. Davis ID, Greenbaum LA, Gipson D, Wu LL, Sinha R, Matsuda-Abedini M, Emancipator JL, Lane JC, Hodgkins K, Nailescu C, et al. Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2012;27(3):451-9.
9. Roumelioti ME, Wentz A, Schneider MF, Gerson AC, Hooper S, Benfield M, Warady BA, Furth SL, Unruh ML. Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study. Am J Kidney Dis. 2010;55(2):269-80.
10. Tong A, Henning P, Wong G, McTaggart S, Mackie F, Carroll RP, Craig JC. Experiences and perspectives of adolescents and young adults with advanced CKD. Am J Kidney Dis. 2013;61(3):375-84.
11. Lande MB, Gerson AC, Hooper SR, Cox C, Matheson M, Mendley SR, Gipson DS, Wong C, Warady BA, Furth SL, et al. Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol. 2011;6(8):1831-7.
12. Haavisto A, Korkman M, Holmberg C, Jalanko H, Qvist E. Neuropsychological profile of children with kidney transplants. Nephrol Dial Transplant. 2012;27(6):2594-601.
13. Hooper SR, Gerson AC, Johnson RJ, Mendley SR, Shinnar S, Lande MB, Matheson MB, Gipson DS, Morgenstern B, Warady BA, et al. Neurocognitive, social-behavioural, and adaptive functioning in preschool children with mild to moderate kidney disease. J Dev Behav Pediatr. 2016:Feb 17. [E-pub head of print].
14. Thys K, Schwering KL, Siebelink M, Dobbels F, Borry P, Schotsmans P, Aujoulat I. Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors, and the family: a systematic review. Transplant Int. 2015;28(3):270-80.
15. Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Maurice-Stam H, Grootenhuis MA, Groothoff JW. Long-term quality of life and social outcome of childhood end-stage renal disease. J Pediatr. 2014;165(2):336-42.
16. Lewis H, Mark SD. Differences between paediatric and adult presentation of ESKD in attainment of adult social goals. Pediatr Nephrol. 2014;29(12):2379-85.
17. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JP, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156-65.
18. Cochrane Central Register of Controlled Trials (CENTRAL). Available at http://onlinelibrary.wiley.com/cochranelibrary/search?searchRow.searchOptions.searchProducts=clinicalTrialsDoi. Accessed 11 Mar 2016.
19. Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol. 2013;8(5):824-32.
20. Schmitt CP, Nau B, Gemulla G, Bonzel KE, Hölttä T, Testa S, Fischbach M, John U, Kemper MJ, Sander A, et al. Effect of the dialysis fluid buffer on peritoneal membrane function in children. Clin J Am Soc Nephrol. 2013;8(1):108-15.
21. Goldstein SL, Morris D, Warady BA. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Am J Kidney Dis. 2013;61(4):588-97.
22. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol. 2000;14(7):701-6.
23. Hahn D, Hodson EM, Craig JC. Interventions for metabolic bone disease in children with chronic kidney disease. Cochr Data Sys Rev. 2015;11:D008327.
24. Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2012;2:CD003264.
25. Chaturvedi S, Jones C. Protein restriction for children with chronic kidney disease. Cochr Data Sys Rev. 2007;4:CD006863.
26. Albaramki J, Hodson EM, Craig JC, Webster AC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012;1:CD007857.
27. Sattoe JN, Hilberink SR, Peeters MA, van Staa A. 'Skills for growing up': supporting autonomy in young people with kidney disease. J Ren Care. 2014;40(2):131-9.
28. Nicholas DB, Picone G, Selkirk EK. The lived experiences of children and adolescents with end-stage renal disease. Qual Health Res. 2011;21(2):162-73.
29. Tjaden L, Tong A, Henning P, Groothoff J, Craig JC. Children's experiences of dialysis: a systematic review of qualitative studies. Arch Dis Child. 2012;97(5):395-402.
30. Ruebner RL, Laney N, Kim JY, Hartung EA, Hooper SR, Radcliffe J, Furth SL. Neurocognitive dysfunction in children, adolescents, and young adults with CKD. Am J Kidney Dis. 2016;67(4):567-75.
31. Prinsen CA, Vohra S, Rose MR, King-Jones S, Ishaque S, Bhaloo Z, Adams D, Terwee CB. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'. Trials. 2014;15:247.
32. Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Eng J Med. 2016;376(6):504-6.
33. Harman NL, Bruce IA, Callery P, Tierney S, Sharif MO, O'Brien K, Williamson PR. MOMENT-Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14:70.
34. Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O'Brien K, Bennett AM, Chorbachi R, Hall PN, Harding-Bell A, et al. The importance of integration of stakeholder views in core outcome set development: otitis media with effusion in children with cleft palate. PLoS One. 2015;10(6):e0129514.
35. Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012;13:103.
36. Morris C, Janssens A, Shilling V, Allard A, Fellowes A, Tomlinson R, Williams J, Thompson Coon J, Rogers M, Beresford B, et al. Meaningful health outcomes for paediatric neurodisability: stakeholder prioritisation and appropriateness of patient reported outcome measures. Health Qual Life Outcomes. 2015;13:87.
37. McConachie H, Parr JR, Glod M, Hanratty J, Livingstone N, Oono IP, Robalino S, Baird G, Beresford B, Charman T, et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. Health Technol Assess. 2015;19(41):1-506.
38. Vargus-Adams JN, Martin LK. Measuring what matters in cerebral palsy: a breadth of important domains and outcome measures. Arch Phys Med Rehabil. 2009;90(12):2089-95.
39. Selewski DT, Massengill SF, Troost JP, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, et al. Gaining the patient reported outcomes measurement information system (PROMIS) perspective in chronic kidney diseases: a Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol. 2014;29(12):2347-56.
40. Williams K, Thomson D, Seto I, Contopoulos-Ioannidis DG, Ioannidis JP, Curtis S, Constantin E, Batmanabane G, Hartling L, Klassen T. Standard 6: age groups for pediatric trials. Pediatr. 2012;129(S3):S153-160.
41. Boers M, Kirwan JR, Tugwell P, Beaton D, Binghma III CO, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, et al. The OMERACT Handbook. 2014.
42. Stucki G, Boonen A, Tugwell P, Cieza A, Boers M. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process. J Rheumatol. 2007;34(3):600-6.
43. Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96(6):875-81.
44. Howell M, Tong A, Wong G, Craig JC, Howard K. Important outcomes for kidney transplant recipients: a nominal group and qualitative study. Am J Kidney Dis. 2012;60(2):186-96.
45. Sanderson T, Hewlett S, Richards P, Morris M, Calnan M. Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J Health Psychol. 2012;17:132-42.
46. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, et al. Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique stud. Am J Kidney Dis. 2016. doi: 10.1053/j.ajkd.2016.02.037. [Epub ahead of print].
47. Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ. 1995;311:376-80.
48. MacPhail A. Nominal group technique: a useful method for working with young people. Br Educ Res J. 2001;27(2):161-70.
49. Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW, O'Neill SG, Ralph AF, Craig JC, Tong A. Lupus means sacrifices - the perspectives of adolescents and young adults with systemic lupus erythematosus. Arthritis Care Res. 2016;68(6):828-37.
50. Ronen GM, Rosenbaum P, Law M, Streiner DL. Health-related quality of life in childhood disorders: a modified focus group technique to involve children. Qual Life Res. 2001;10:17-79.
51. Tong A, Sainsbury P, Craig JC. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):249-57.
52. Blackwood B, Ringrow S, Clarke M, Marshall J, Rose L, Williamson P, McAuley D. Core Outcomes in Ventilation Trials (COVenT): protocol for a core outcome set using a Delphi survey with a nested randomised trial and observational cohort study. Trials. 2015;16:368.
53. Chiarotto A, Terwee CB, Deyo RA, Boers M, Lin CW, Buchbinder R, Corbin TP, Costa LO, Foster NE, Grotle M, et al. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set. Trials. 2014;15:511.
54. MacLennan S, Bekema HJ, Williamson PR, Campbell MK, Stewart F, MacLennan SJ, N'Dow JM, Lam TB. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey. Trials. 2015;16:76.
55. Chiarotto A, Deyo RA, Terwee CB, Boers M, Buchbinder R, Corbin TP, Costa LO, Foster NE, Grotle M, Koes BW, et al. Core outcome domains for clinical trials in non-specific low back pain. Eur Spine J. 2015;24(6):1127-42.
56. van't Hooft J, Duffy JM, Daly M, Williamson PR, Meher S, Thom E, Saade GR, Alfirevic Z, Mol BW, Khan KS. A core outcome set for evaluation of interventions to prevent preterm birth. Obstet Gynecol. 2016;127(1):49-58.
57. Potter S, Holcombe C, Ward JA, Blazeby JM. Development of a core outcome set for research and audit studies in reconstructive breast surgery. Br J Surg. 2015;102(11):1360-71.
58. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393.
59. Linstone HA, Turoff M. The Delphi Method: techniques and applications. London UK: Addison Wesley Publishing Company; 1975.
60. Atkins R, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol. 2005;5:37.
61. Schunemann H, Brozek J, Oxman AD. GRADE handbook for grading quality of evidence and strength of recommendation, vol. version 3.2. 2009.